These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2179276)

  • 1. Biochemical, endocrine, and mineral effects of indapamide in black women.
    Prisant LM; Beall SP; Nichoalds GE; Feldman EB; Carr AA; Feldman DS; Hames CG
    J Clin Pharmacol; 1990 Feb; 30(2):121-6. PubMed ID: 2179276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.
    Weidmann P; Bianchetti MG; Mordasini R
    Curr Med Res Opin; 1983; 8 Suppl 3():123-34. PubMed ID: 6137325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.
    Ames RP
    Am J Cardiol; 1996 Feb; 77(6):12b-16b. PubMed ID: 8848987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoproteins during treatment with the antihypertensive agent indapamide.
    Gerber A; Weidmann P; Bianchetti MG; Ferrier C; Laederach K; Mordasini R; Riesen W; Bachmann C
    Hypertension; 1985; 7(6 Pt 2):II164-9. PubMed ID: 4077235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.
    Weidmann P
    Drug Saf; 2001; 24(15):1155-65. PubMed ID: 11772148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice.
    Farsang C;
    Blood Press; 2013 Sep; 22 Suppl 1():3-10. PubMed ID: 23163322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoprotein levels during long-term treatment of hypertension with indapamide.
    Meyer-Sabellek W; Gotzen R; Heitz J; Arntz HR; Schulte KL
    Hypertension; 1985; 7(6 Pt 2):II170-4. PubMed ID: 4077236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indapamide in the treatment of essential arterial hypertension: results of a controlled study.
    Plante GE; Robillard C
    Curr Med Res Opin; 1983; 8 Suppl 3():59-66. PubMed ID: 6352186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
    Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
    Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors associated with elevation of uric acid after treatment with thiazide-like diuretic in patients with essential hypertension.
    Ohta Y; Kamide K; Hanada H; Morimoto S; Nakahashi T; Takiuchi S; Ishimitsu T; Tsuchihashi T; Soma M; Tomohiro Katsuya T; Sugimoto K; Rakugi H; Oukura T; Higaki J; Matsuura H; Shinagawa T; Miwa Y; Sasaguri T; Igase M; Miki T; Takeda K; Higashiura K; Shimamoto K; Katabuchi R; Ueno M; Hosomi N; Kato J; Komai N; Kojima S; Sase K; Iwashima Y; Yoshihara F; Horio T; Nakamura S; Nakahama H; Miyata T; Kawano Y
    Hypertens Res; 2020 Mar; 43(3):220-226. PubMed ID: 31748705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
    Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
    Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes.
    Raggi U; Palumbo P; Moro B; Bevilacqua M; Norbiato G
    Hypertension; 1985; 7(6 Pt 2):II157-60. PubMed ID: 4077234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters.
    Inaba M; Noguchi Y; Yamamoto T; Imai T; Hatano M; Yagi S; Katayama S
    Hypertens Res; 2004 Mar; 27(3):141-5. PubMed ID: 15080372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide: a review.
    Reyes AJ; Leary WP
    S Afr Med J; 1983 Nov; Suppl():1-6. PubMed ID: 6356402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.